Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,284,725
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
2,138,466
-
Shares change
-
+639,202
-
Total reported value, excl. options
-
$20,744,048
-
Value change
-
+$6,193,891
-
Number of buys
-
6
-
Number of sells
-
-9
-
Price
-
$9.7
Significant Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q4 2019
22 filings reported holding IMUX - IMMUNIC, INC. - Common Stock as of Q4 2019.
IMMUNIC, INC. - Common Stock (IMUX) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,138,466 shares
of 120,284,725 outstanding shares and own 1.78% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (1,371,494 shares), Artal Group S.A. (630,019 shares), RENAISSANCE TECHNOLOGIES LLC (60,631 shares), BlackRock Inc. (34,001 shares), VANGUARD GROUP INC (11,520 shares), MILLENNIUM MANAGEMENT LLC (11,463 shares), Verition Fund Management LLC (11,301 shares), WELLS FARGO & COMPANY/MN (6,029 shares), Tower Research Capital LLC (TRC) (1,300 shares), and INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC (297 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.